Efficient light-induced reactive oxygen species production from a far-red ER-targeting BODIPY dye.

Generation of reactive oxygen species (ROS) within the ER evokes stress leading to immunogenic cell death. A red light activated BODIPY dye capable of subcellular localization within the ER producing high quantum yields of ROS is reported. The ability of this dye to act as a photodynamic therapy (PDT) agent in breast cancer cells suggests promising organelle-targeted therapeutics.

Electropolymerization on ITO-Coated Glass Slides of a Series of π-Extended BODIPY Dyes with Redox-Active Meso-Substituents.

A series of meso-carbazole and meso-pyrene boron dipyrromethene(BDP) dyes have been synthesized using a two-step method. This simplified synthetic method did not require catalysts or oxidizing agents. Solution spectroscopic and electrochemical studies indicate that the HOMO and LUMO energies are dependent on the extent of π-conjugation associated with the pyrroles.

A Cationic Porphyrin, ZnPor, Disassembles Biofilm Matrix, Kills Cells Directly, and Enhances Antibiotic Activity of Tobramycin.

One of the greatest threats to human health is the rise in antibiotic-resistant bacterial infections. (PsA) is an "opportunistic" pathogen known to cause life-threatening infections in immunocompromised individuals and is the most common pathogen in adults with cystic fibrosis (CF). We report here a cationic zinc (II) porphyrin, ZnPor, that effectively kills planktonic and biofilm-associated cells of PsA.

Ruthenium(II) Polypyridyl Complexes Coordinated Directly to the Pyrrole Backbone of π-Extended Boron Dipyrromethene (Bodipy) Dyes: Synthesis, Characterization, and Spectroscopic and Electrochemical Properties.

A series of new Bodipy dyes incorporating the π-extended isoquino[5,6-c]pyrrole have been synthesized and characterized. The dyes display intense Bodipy (π-π*) transitions and emissions with high quantum efficiencies. Spectroscopic, electrochemical, and theoretical calculations are used to give insight into the frontier orbitals.

Heteroleptic monometallic and trimetallic ruthenium(II) complexes incorporating a π-extended dipyrrin ligand: Light-activated reactions with the A549 lung cancer cell line.

A heteroleptic monometallic ruthenium(II) and a heteroleptic trimetallic ruthenium(II) complex have been synthesized and characterized. Both complexes have an overall 3+ charge, with the charge density greater for the monometallic complex. The electronic spectra of the monometallic ruthenium(II) complex exhibits intense π-π* transitions associated with the bipyridyl groups along with overlapping metal to ligand charge transfer (MLCT) and ligand centered π-π* transitions ranging from 520nm to approximately 600nm.

Photoinduced interactions of supramolecular ruthenium(II) complexes with plasmid DNA: synthesis and spectroscopic, electrochemical, and DNA photocleavage studies.

Two new bridging ligands have been synthesized by combining substituted benzaldehydes with phenanthrolinopyrrole (php), resulting in new polyazine bridging ligands. The ligands have been characterized by (1)H NMR, mass spectroscopy, and elemental analysis. These new ligands display π-π* transitions above 500 nm with modest molar absorptivities.

Toxicity and localization studies of a potential photodynamic therapy agent in Drosophila.

Photodynamic therapy utilizes light, a photosensitizer, and molecular oxygen as a treatment modality for a variety of cancers. We have recently combined ruthenium(II) polypyridyl groups with a zinc(II) centered porphyrin as a new photosensitizer for the treatment of melanoma. In-vitro studies have indicated that this photosensitizer is toxic to melanoma cells when irradiated with low energy light; however, it is nontoxic to normal cells under similar conditions.

Nickel, copper, and zinc centered ruthenium-substituted porphyrins: effect of transition metals on photoinduced DNA cleavage and photoinduced melanoma cell toxicity.

Coordination of two [Ru(bipy)(2)Cl](+) moieties (where bipy = 2,2'-bipyridine) to the pyridyl nitrogens in the 5,10-positions of meso-5,10,15-(4-pyridyl)-20-(pentafluorophenyl)porphyrin gives the diruthenium porphyrin complex I. Insertion of nickel(II), copper(II), and zinc(II) into the porphyrin center gives the complexes II-IV, respectively. Electronic transitions associated with the ruthenium porphyrin include an intense Soret band and four less intense Q-bands in the visible region of the spectrum.

Light induced photoreactions with plasmid DNA by Cu/Ru and Cu/Ru/Pt multi-metallic porphyrins.

Coordination of two [Ru(bipy)(2)Cl](+) moieties (where bipy = 2,2'-bipyridine) to the pyridyl nitrogens in the 5,10-positions of meso-5,10,15-(4-Pyridyl)-20-(pentafluorophenyl)porphyrin gives the diruthenium porphyrin complex II. Insertion of copper(II) into the porphyrin center allows for the third pyridyl nitrogen to coordinate to Pt(dmso)Cl(2). Electronic transitions associated with the ruthenium porphyrin include an intense Soret band and four less intense Q-bands in the visible region of the spectrum.

A fluorinated ruthenium porphyrin as a potential photodynamic therapy agent: synthesis, characterization, DNA binding, and melanoma cell studies.

When the new porphyrin 5,10-(4-pyridyl)-15,20-(pentafluorophenyl)porphyrin is reacted with 2 equiv of Ru(bipy)(2)Cl(2) (where bipy = 2,2'-bipyridine) formation of the target ruthenated porphyrin is achieved with 40% yield. Strong electronic transitions are observed in the visible region of the spectrum associated with the porphyrin Soret and four Q-bands. A shoulder at slightly higher energy than the Soret band is attributed to the Ru(dpi) to bipy(pi*) metal to ligand charge transfer (MLCT) band.

Neodymium, gadolinium, and terbium complexes containing hexafluoroacetylacetonate and 2,2'-bipyrimidine: structural and spectroscopic characterization.

Lanthanide complexes of the form Ln(hfa)3bpm (where Ln=Nd(III), Gd(III), or Tb(III); hfa=1,1,1,5,5,5-hexafluoroacetylacetone and bpm=2,2'-bipyrimidine) have been structurally characterized. The Nd and Gd complexes form one-dimensional arrays when X-ray-quality crystals are grown by the slow evaporation of concentrated solutions of the complexes. Each metal is 10-coordinate with repeating Ln-bpm units.

Electrocatalytic reduction of oxygen at electrodes coated with a bimetallic cobalt(II)/platinum(II) porphyrin.

Edge plane pyrolytic graphite (EPG) electrodes coated with 5-(4-pyridyl)-10,15,20-tris(3-methoxy-4-hydroxyphenyl)porphyrin and its Pt(II) and Co(II)/Pt(II) analogs undergo an electrochemical-chemical-electrochemical (ECE) reaction when anodically scanned in 1.0 M HClO4. The new redox couple formed from this anodic conditioning of the coated electrode is dependent on the pH of the solution.

The twinned crystal structure of mu-2,2'-bipyrimidine-1kappa2N1,N1':2kappa2N3,N3'-bis{tris[4,4,4-trifluoro-1-(2-thienyl)butane-1,3-dionato-kappa2O,O']terbium(III)} ethyl acetate solvate.

The title compound, [Tb2(C24H12F9O6S3)2(C8H6N4)].C4H8O2, has two terbium(III) centers bridged by the polyazine ligand 2,2'-bipyrimidine (bpm), which is distorted from planarity by 7.0 (2) degrees .

Design aspects for the development of mixed-metal supramolecular complexes capable of visible light induced photocleavage of DNA.

Mixed-metal supramolecular complexes that couple ruthenium or osmium based light absorbers to a central rhodium(III) core have been designed which photocleave DNA upon irradiation with visible light. The complexes [[(bpy)(2)Ru(dpp)](2)RhCl(2)](PF(6))(5), [[(bpy)(2)Os(dpp)](2)RhCl(2)](PF(6))(5), and [[(tpy)RuCl(dpp)](2)RhCl(2)](PF(6))(3), where bpy = 2,2'-bipyridine, tpy = 2,2':6',2' '-terpyridine, and dpp = 2,3-bis(2-pyridyl)pyrazine, all exhibit intense metal to ligand charge transfer (MLCT) based transitions in the visible but possess lower lying metal to metal charge transfer (MMCT) excited states. These supramolecular complexes with low lying MMCT states photocleave DNA when excited into their intense MLCT transitions.

Visible light induced photocleavage of DNA by a mixed-metal supramolecular complex: [[(bpy)(2)Ru(dpp)](2)RhCl2]5+.

The mixed-metal supramolecular complex, [[(bpy)(2)Ru(dpp)](2)RhCl(2)](PF(6))(5) (bpy = 2,2'-bipyridine and dpp = 2,3-bis(2-pyridyl)pyrazine) coupling two ruthenium light absorbers (LAs) to a central rhodium, has been shown to photocleave DNA. This system possesses a lowest lying metal to metal charge transfer (MMCT) excited state in contrast to the metal to ligand charge transfer states (MLCT) of the bpm and Ir analogues. The systems with an MLCT excited state do not photocleavage DNA.

Synthesis and study of Ru,Rh,Ru triads: modulation of orbital energies in a supramolecular architecture.

Supramolecular trimetallic complexes [((tpy)RuCl(BL))(2)RhCl(2)](3+) where tpy = 2,2':6',2' '-terpyridine and BL = dpp or bpm [dpp = 2,3-bis(2-pyridyl)pyrazine and bpm = 2,2'-bipyrimidine] have been synthesized and characterized. The mixed-metal complexes couple a reactive rhodium(III) center to two ruthenium(II) light absorbers to form a light absorber-electron collector-light absorber triad. The variation of the bridging (dpp and bpm) and terminal (tpy in lieu of bpy) ligands has some profound effects on the properties of these complexes, and they are remarkably different from the previously reported [((bpy)(2)Ru(bpm))(2)RhCl(2)](5+) system.

Mixed-metal supramolecular complexes coupling phosphine-containing Ru(II) light absorbers to a reactive Pt(II) through polyazine bridging ligands.

Supramolecular bimetallic Ru(II)/Pt(II) complexes [(tpy)Ru(PEt(2)Ph)(BL)PtCl(2)](2+) and their synthons [(tpy)Ru(L)(BL)](n)()(+) (where L = Cl(-), CH(3)CN, or PEt(2)Ph; tpy = 2,2':6',2''-terpyridine; and BL = 2,2'-bipyrimidine (bpm) or 2,3-bis(2-pyridyl)pyrazine (dpp)) have been synthesized and studied by cyclic voltammetry, electronic absorption spectroscopy, mass spectral analysis, and (31)P NMR. The mixed-metal bimetallic complexes couple phosphine-containing Ru chromophores to a reactive Pt site. These complexes show how substitution of the monodentate ligand on the [(tpy)RuCl(BL)](+) synthons can tune the properties of these light absorbers (LA) and incorporate a (31)P NMR tag by addition of the PEt(2)Ph ligand.